Nicholas Day
YOU?
Author Swipe
View article: Supplementary Table 1 from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
Supplementary Table 1 from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study Open
Supplementary Table 1 from TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
View article: Supplementary Table 1 from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
Supplementary Table 1 from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study Open
Supplementary Table 1 from TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
View article: Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study Open
In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The E…
View article: Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study
Data from <i>TP53</i> and <i>KRAS2</i> Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study Open
In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The E…